Sanofi tip ends in $465M settlement between Mylan and DOJ

17th August 2017 Uncategorised 0

Despite the criticism and calls for the government to get a better deal out of Mylan, the drugmaker announced on Thursday that it finalized a settlement with the Department of Justice for $465 million relating to EpiPen’s misclassification on Medicaid. Interestingly, the whole episode started with a tip from Sanofi, which previously marketed a competing product.

More: Sanofi tip ends in 5M settlement between Mylan and DOJ
Source: fierce